Your browser doesn't support javascript.
loading
Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.
Stanford, S Clare; Heal, David J.
Afiliação
  • Stanford SC; Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK. c.stanford@ucl.ac.uk.
  • Heal DJ; DevelRx Ltd, BioCity, Nottingham, UK.
Handb Exp Pharmacol ; 2023 Jul 27.
Article em En | MEDLINE | ID: mdl-37495853
ABSTRACT
Research into the involvement of adrenoceptor subtypes in the cause(s) of psychiatric disorders is particularly challenging. This is partly because of difficulties in developing animal models that recapitulate the human condition but also because no evidence for any causal links has emerged from studies of patients. These, and other obstacles, are outlined in this chapter. Nevertheless, many drugs that are used to treat psychiatric disorders bind to adrenoceptors to some extent. Direct or indirect modulation of the function of specific adrenoceptor subtypes mediates all or part of the therapeutic actions of drugs in various psychiatric disorders. On the other hand, interactions with central or peripheral adrenoceptors can also explain their side effects. This chapter discusses both aspects of the field, focusing on disorders that are prevalent depression, schizophrenia, anxiety, attention-deficit hyperactivity disorder, binge-eating disorder, and substance use disorder. In so doing, we highlight some unanswered questions that need to be resolved before it will be feasible to explain how changes in the function of any adrenoceptor subtype affect mood and behavior in humans and other animals.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article